Novartis to buy neuroscience company Cadent for up to US$770 million

Retrieved on: 2020-12-17 06:22:30

Tags for this article:

Pharmaceutical companies

Life Sciences

Novartis

Cadent

Companies

Click the tags to see associated articles and topics

Novartis to buy neuroscience company Cadent for up to US$770 million. View article details on hiswai:

Excerpt

Novartis said on Thursday it had entered into an agreement to acquire U.S.-based <b>neuroscience</b> company Cadent for up to US$770 million, gaining ...

Article found on: www.channelnewsasia.com

View Original Article